Table 4.
Variables | CDC − FC− (n = 274) |
CDC − FC+ (n = 39) |
CDC + FC+ (n = 17) |
P |
---|---|---|---|---|
UTI | 21 (7.7%) | 19 (51.3%) | 4 (23.5%) | < 0.001 |
Bacterial pneumonia | 4 (1.5%) | 2 (5.1%) | 0 | 0.234 |
Bacteremia | 7 (2.6%) | 5 (12.8%) | 0 | 0.004 |
Intraabdominal infection | 2 (0.7%) | 3 (7.7%) | 0 | 0.003 |
BKV viremia | 18 (6.6%) | 2 (5.1%) | 0 | 0.527 |
Herpes zoster | 20 (7.3%) | 3 (7.7%) | 5 (29.4%) | 0.006 |
PJP | 0 | 1 (2.6%) | 2 (11.8%) | < 0.001 |
CMV viremia | 38 (13.9%) | 19 (48.7%) | 11 (64.7%) | < 0.001 |
BKV BK virus, CDC Complement dependent cytotoxicity, CMV Cytomegalovirus, FC Flow cytometry, PCP Pneumocystis jirovecii pneumonia, UTI Urinary tract infection